S&P 500   3,972.35 (-2.85%)
DOW   31,867.80 (-2.41%)
QQQ   296.67 (-3.10%)
AAPL   143.66 (-3.74%)
MSFT   257.44 (-3.52%)
FB   196.20 (-3.17%)
GOOGL   2,266.55 (-2.70%)
AMZN   2,184.05 (-5.34%)
TSLA   734.00 (-3.63%)
NVDA   174.26 (-4.13%)
BABA   89.65 (-2.54%)
NIO   16.23 (-2.41%)
AMD   99.31 (-3.08%)
CGC   5.76 (-2.21%)
MU   72.25 (-2.99%)
T   20.42 (-0.73%)
GE   75.64 (-0.99%)
F   13.02 (-3.77%)
DIS   105.79 (-2.62%)
AMC   13.28 (+2.95%)
PFE   50.63 (-1.38%)
PYPL   78.30 (-1.82%)
NFLX   183.55 (-3.68%)
S&P 500   3,972.35 (-2.85%)
DOW   31,867.80 (-2.41%)
QQQ   296.67 (-3.10%)
AAPL   143.66 (-3.74%)
MSFT   257.44 (-3.52%)
FB   196.20 (-3.17%)
GOOGL   2,266.55 (-2.70%)
AMZN   2,184.05 (-5.34%)
TSLA   734.00 (-3.63%)
NVDA   174.26 (-4.13%)
BABA   89.65 (-2.54%)
NIO   16.23 (-2.41%)
AMD   99.31 (-3.08%)
CGC   5.76 (-2.21%)
MU   72.25 (-2.99%)
T   20.42 (-0.73%)
GE   75.64 (-0.99%)
F   13.02 (-3.77%)
DIS   105.79 (-2.62%)
AMC   13.28 (+2.95%)
PFE   50.63 (-1.38%)
PYPL   78.30 (-1.82%)
NFLX   183.55 (-3.68%)
S&P 500   3,972.35 (-2.85%)
DOW   31,867.80 (-2.41%)
QQQ   296.67 (-3.10%)
AAPL   143.66 (-3.74%)
MSFT   257.44 (-3.52%)
FB   196.20 (-3.17%)
GOOGL   2,266.55 (-2.70%)
AMZN   2,184.05 (-5.34%)
TSLA   734.00 (-3.63%)
NVDA   174.26 (-4.13%)
BABA   89.65 (-2.54%)
NIO   16.23 (-2.41%)
AMD   99.31 (-3.08%)
CGC   5.76 (-2.21%)
MU   72.25 (-2.99%)
T   20.42 (-0.73%)
GE   75.64 (-0.99%)
F   13.02 (-3.77%)
DIS   105.79 (-2.62%)
AMC   13.28 (+2.95%)
PFE   50.63 (-1.38%)
PYPL   78.30 (-1.82%)
NFLX   183.55 (-3.68%)
S&P 500   3,972.35 (-2.85%)
DOW   31,867.80 (-2.41%)
QQQ   296.67 (-3.10%)
AAPL   143.66 (-3.74%)
MSFT   257.44 (-3.52%)
FB   196.20 (-3.17%)
GOOGL   2,266.55 (-2.70%)
AMZN   2,184.05 (-5.34%)
TSLA   734.00 (-3.63%)
NVDA   174.26 (-4.13%)
BABA   89.65 (-2.54%)
NIO   16.23 (-2.41%)
AMD   99.31 (-3.08%)
CGC   5.76 (-2.21%)
MU   72.25 (-2.99%)
T   20.42 (-0.73%)
GE   75.64 (-0.99%)
F   13.02 (-3.77%)
DIS   105.79 (-2.62%)
AMC   13.28 (+2.95%)
PFE   50.63 (-1.38%)
PYPL   78.30 (-1.82%)
NFLX   183.55 (-3.68%)
OTCMKTS:POLXF

Polydex Pharmaceuticals News Headlines

$0.77
0.00 (0.00%)
(As of 05/17/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.77
$0.77
50-Day Range
$0.77
$1.07
52-Week Range
$0.77
$1.15
Volume
1,565 shs
Average Volume
2,641 shs
Market Capitalization
$2.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.43
Get Polydex Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for POLXF and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Polydex Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

POLXF
News Sentiment

0.67

0.33

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

POLXF Articles
This Week

1

0

POLXF Articles
Average Week



Polydex Pharmaceuticals (OTCMKTS:POLXF) News Headlines Today

SourceHeadline
MarketBeat logoPolydex Pharmaceuticals (OTCMKTS:POLXF) Share Price Passes Below 200 Day Moving Average of $0.97
americanbankingnews.com - May 14 at 2:16 AM
nz.finance.yahoo.com logoMarshall Plan for Moms Mother's Day Mission: Cure Chronic Mom Guilt
nz.finance.yahoo.com - May 4 at 12:43 AM
nz.finance.yahoo.com logoQED Investors Hires Victoria Zuo to Help Scale Early Stage Team
nz.finance.yahoo.com - May 3 at 7:37 PM
MarketBeat logoPolydex Pharmaceuticals (OTCMKTS:POLXF) Stock Price Crosses Below Two Hundred Day Moving Average of $0.96
americanbankingnews.com - May 3 at 3:02 AM
MarketBeat logoPolydex Pharmaceuticals (OTCMKTS:POLXF) Share Price Crosses Below 200-Day Moving Average of $0.97
americanbankingnews.com - April 23 at 3:28 AM
nasdaq.com logoPolydex Pharmaceuticals Inc (POLXF)
nasdaq.com - January 29 at 10:59 PM
finance.yahoo.com logoPolydex Pharmaceuticals Announces Collaboration with Termanox Water Treatment Solutions for novel use of Native Dextran
finance.yahoo.com - January 26 at 10:28 AM
nz.finance.yahoo.com logoGlobal Plastic Recycling Market Witnessing an Upward Growth Trajectory—Projected to Reach USD 71.5 Billion by 2027 | BlueWeave
nz.finance.yahoo.com - December 17 at 8:39 AM
nz.finance.yahoo.com logoTP-Link Reveals Flagship Archer AX6600 Tri-Band Wi-Fi 6 Gaming Router for just $249.99
nz.finance.yahoo.com - September 16 at 8:11 PM
finance.yahoo.com logoPolydex Pharmaceuticals Issues Third Quarter Financial Results
finance.yahoo.com - December 15 at 1:06 PM
finance.yahoo.com logoPolydex Pharmaceuticals Issues First Quarter Financial Results
finance.yahoo.com - June 15 at 12:40 PM
finance.yahoo.com logoPolydex Pharmaceuticals Provides Year End Financial Report Closing the Year With A Strong Cash Position and Low Debt
finance.yahoo.com - April 30 at 6:09 PM
www.fool.com logoPolydex Pharmaceuticals Limited (USA) (POLXF) - Cash Flow
www.fool.com - March 29 at 9:32 PM
finance.yahoo.com logoPolydex Pharmaceuticals Ltd. Reports 3rd Quarter Financial Results with continued improving gross margins
finance.yahoo.com - December 16 at 7:57 AM
finance.yahoo.com logoPolydex Pharmaceuticals Issues Second Quarter Financial Results
finance.yahoo.com - September 16 at 10:08 AM
finance.yahoo.com logoPolydex Pharmaceuticals Ltd. Reports 3rd Quarter Financial Results with consistent year over year sales
finance.yahoo.com - December 17 at 3:59 PM
Get Polydex Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for POLXF and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 5/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.